Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Deloitte
UBS
Baxter
Merck
Fuji

Generated: August 21, 2019

DrugPatentWatch Database Preview

Patent: 8,252,933

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,252,933
Title:2-oxo-1,2-dihydro-quinoline modulators of immune function
Abstract: The present invention relates to new 2-oxo-1,2-dihydro-quinoline modulators of immune function, pharmaceutical compositions thereof, and methods of use thereof. ##STR00001##
Inventor(s): Gant; Thomas G. (Carlsbad, CA), Shahbaz; Manouchehr M. (Vista, CA)
Assignee: Teva Pharmaceuticals Industries, Ltd. (Petach-Tikva, IL)
Application Number:12/552,663
Patent Claims:see list of patent claims

Details for Patent 8,252,933

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27   Try a Free Trial Teva Pharmaceuticals Industries, Ltd. (Petach-Tikva, IL) 2028-09-03 RX search
Novartis Pharms EXTAVIA interferon beta-1b INJECTABLE; SUBCUTANEOUS 125290 001 2009-08-14   Try a Free Trial Teva Pharmaceuticals Industries, Ltd. (Petach-Tikva, IL) 2028-09-03 RX search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16   Try a Free Trial Teva Pharmaceuticals Industries, Ltd. (Petach-Tikva, IL) 2028-09-03 RX Orphan search
Ucb Inc CIMZIA certolizumab pegol INJECTABLE; INJECTION 125160 001 2008-04-22   Try a Free Trial Teva Pharmaceuticals Industries, Ltd. (Petach-Tikva, IL) 2028-09-03 RX search
Bristol Myers Squibb ORENCIA abatacept INJECTABLE; IV (INFUSION) 125118 001 2005-12-23   Try a Free Trial Teva Pharmaceuticals Industries, Ltd. (Petach-Tikva, IL) 2028-09-03 RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23   Try a Free Trial Teva Pharmaceuticals Industries, Ltd. (Petach-Tikva, IL) 2028-09-03 RX search
Abbvie Inc HUMIRA adalimumab VIAL 125057 002 2002-12-31   Try a Free Trial Teva Pharmaceuticals Industries, Ltd. (Petach-Tikva, IL) 2028-09-03 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 8,252,933

Country Patent Number Publication Date
South Africa 201101403 May 30, 2012
World Intellectual Property Organization (WIPO) 2010028015 Jun 24, 2010
World Intellectual Property Organization (WIPO) 2010028015 Mar 11, 2010
United States of America 2010055072 Mar 04, 2010
Ukraine 104005 Dec 25, 2013
New Zealand 591315 Aug 31, 2012
Mexico 2011002033 May 02, 2011
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Farmers Insurance
McKinsey
Cantor Fitzgerald
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.